Baidu
map

MedSci参加中华医学会第十一届骨科学术会议暨第四届COA国际学术大会

2009-11-25 MedSci原创 MedSci原创

SCI

11月19-22日,中华医学会第十一届骨科学术会议暨第四届COA国际学术大会(Chinese Orthopaedic Association, COA)在美丽的海滨城市厦门胜利召开。本届会议是继北京、郑州、苏州召开后的第四届COA国际学术大会,集中体现了一年来国内外在骨科领域所取得的研究成果,反映出脊柱、创伤、关节、关节镜及运动医学、骨肿瘤、骨质疏松、足踝外科、护理等方面的最新技术和临床进展。

1119-22日,中华医学会第十一届骨科学术会议暨第四届COA国际学术大会(Chinese Orthopaedic Association, COA)在美丽的海滨城市厦门胜利召开。本届会议是继北京、郑州、苏州召开后的第四届COA国际学术大会,集中体现了一年来国内外在骨科领域所取得的研究成果,反映出脊柱、创伤、关节、关节镜及运动医学、骨肿瘤、骨质疏松、足踝外科、护理等方面的最新技术和临床进展。

本次会议规模盛大,约有9000人次参加,邀请到了欧美、港台、中国大陆等地的著名专家和资深人士出席会议并作专题演讲。会场内座无虚席,学术氛围浓厚,会下的交流也极其热烈。同时大会还将邀请了120多家国际国内知名骨科相关企业商家参与其中,展示其最新的产品和技术,是一次医疗工业和医学科研良好的亲密接触。

我们MedSci也积极参与到了此次大会中,并借此良机,和与会的专家学者们展开了亲切的交流!凭借两年多来对国内科研进展及骨科学SCI论文发表情况的了解,MedSci代表和全国各地的骨科学工作者就骨科方面的SCI论文发表特点、难点,以及国内外一些最新的学术进展,进行了广泛而深入的讨论。

令人荣幸的是,在参会的三天中,我们MedSci的工作受到了许许多多专家学者以及新老客户的肯定,这也是对我们多年来努力的最佳回报。今后,我们会秉承节约生物医学领域工作者的宝贵时间,更好地展示母语非英语的医学和科学人士的科研成果这一根本宗旨,为全国科研工作者提供更为完善更为优质的服务!

会议当日注册盛况

Spine分会场

聚精会神的听众

MedSci市场专员Tony会场留影

Tony 与解放军总医院第一附属医院骨科主任 吴闻文教授合影

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1904650, encodeId=b6f4190465064, content=<a href='/topic/show?id=85fa455346c' target=_blank style='color:#2F92EE;'>#学术会议#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45534, encryptionId=85fa455346c, topicName=学术会议)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Fri Jun 04 18:46:00 CST 2010, time=2010-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1699536, encodeId=8f86169953640, content=<a href='/topic/show?id=15a24951c2' target=_blank style='color:#2F92EE;'>#COA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4951, encryptionId=15a24951c2, topicName=COA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=224929955832, createdName=circumcision, createdTime=Sat Aug 21 16:46:00 CST 2010, time=2010-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=929, encodeId=6d899293e, content=我也看到了你们了,你们的工作人员水平很高。, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=小医生, createdTime=Wed Jan 06 17:28:00 CST 2010, time=2010-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605513, encodeId=79e61605513c8, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Nov 27 00:46:00 CST 2009, time=2009-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=798, encodeId=e151e98e0, content=我也去了~看到你们发的材料了~, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=116.233.218.98, createdTime=Wed Nov 25 12:57:00 CST 2009, time=2009-11-25, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1904650, encodeId=b6f4190465064, content=<a href='/topic/show?id=85fa455346c' target=_blank style='color:#2F92EE;'>#学术会议#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45534, encryptionId=85fa455346c, topicName=学术会议)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Fri Jun 04 18:46:00 CST 2010, time=2010-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1699536, encodeId=8f86169953640, content=<a href='/topic/show?id=15a24951c2' target=_blank style='color:#2F92EE;'>#COA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4951, encryptionId=15a24951c2, topicName=COA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=224929955832, createdName=circumcision, createdTime=Sat Aug 21 16:46:00 CST 2010, time=2010-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=929, encodeId=6d899293e, content=我也看到了你们了,你们的工作人员水平很高。, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=小医生, createdTime=Wed Jan 06 17:28:00 CST 2010, time=2010-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605513, encodeId=79e61605513c8, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Nov 27 00:46:00 CST 2009, time=2009-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=798, encodeId=e151e98e0, content=我也去了~看到你们发的材料了~, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=116.233.218.98, createdTime=Wed Nov 25 12:57:00 CST 2009, time=2009-11-25, status=1, ipAttribution=)]
    2010-08-21 circumcision
  3. [GetPortalCommentsPageByObjectIdResponse(id=1904650, encodeId=b6f4190465064, content=<a href='/topic/show?id=85fa455346c' target=_blank style='color:#2F92EE;'>#学术会议#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45534, encryptionId=85fa455346c, topicName=学术会议)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Fri Jun 04 18:46:00 CST 2010, time=2010-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1699536, encodeId=8f86169953640, content=<a href='/topic/show?id=15a24951c2' target=_blank style='color:#2F92EE;'>#COA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4951, encryptionId=15a24951c2, topicName=COA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=224929955832, createdName=circumcision, createdTime=Sat Aug 21 16:46:00 CST 2010, time=2010-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=929, encodeId=6d899293e, content=我也看到了你们了,你们的工作人员水平很高。, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=小医生, createdTime=Wed Jan 06 17:28:00 CST 2010, time=2010-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605513, encodeId=79e61605513c8, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Nov 27 00:46:00 CST 2009, time=2009-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=798, encodeId=e151e98e0, content=我也去了~看到你们发的材料了~, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=116.233.218.98, createdTime=Wed Nov 25 12:57:00 CST 2009, time=2009-11-25, status=1, ipAttribution=)]
    2010-01-06 小医生

    我也看到了你们了,你们的工作人员水平很高。

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1904650, encodeId=b6f4190465064, content=<a href='/topic/show?id=85fa455346c' target=_blank style='color:#2F92EE;'>#学术会议#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45534, encryptionId=85fa455346c, topicName=学术会议)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Fri Jun 04 18:46:00 CST 2010, time=2010-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1699536, encodeId=8f86169953640, content=<a href='/topic/show?id=15a24951c2' target=_blank style='color:#2F92EE;'>#COA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4951, encryptionId=15a24951c2, topicName=COA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=224929955832, createdName=circumcision, createdTime=Sat Aug 21 16:46:00 CST 2010, time=2010-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=929, encodeId=6d899293e, content=我也看到了你们了,你们的工作人员水平很高。, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=小医生, createdTime=Wed Jan 06 17:28:00 CST 2010, time=2010-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605513, encodeId=79e61605513c8, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Nov 27 00:46:00 CST 2009, time=2009-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=798, encodeId=e151e98e0, content=我也去了~看到你们发的材料了~, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=116.233.218.98, createdTime=Wed Nov 25 12:57:00 CST 2009, time=2009-11-25, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1904650, encodeId=b6f4190465064, content=<a href='/topic/show?id=85fa455346c' target=_blank style='color:#2F92EE;'>#学术会议#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45534, encryptionId=85fa455346c, topicName=学术会议)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Fri Jun 04 18:46:00 CST 2010, time=2010-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1699536, encodeId=8f86169953640, content=<a href='/topic/show?id=15a24951c2' target=_blank style='color:#2F92EE;'>#COA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4951, encryptionId=15a24951c2, topicName=COA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=224929955832, createdName=circumcision, createdTime=Sat Aug 21 16:46:00 CST 2010, time=2010-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=929, encodeId=6d899293e, content=我也看到了你们了,你们的工作人员水平很高。, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=小医生, createdTime=Wed Jan 06 17:28:00 CST 2010, time=2010-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605513, encodeId=79e61605513c8, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Nov 27 00:46:00 CST 2009, time=2009-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=798, encodeId=e151e98e0, content=我也去了~看到你们发的材料了~, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=116.233.218.98, createdTime=Wed Nov 25 12:57:00 CST 2009, time=2009-11-25, status=1, ipAttribution=)]
    2009-11-25 116.233.218.98

    我也去了~看到你们发的材料了~

    0

相关资讯

怎样在国际权威杂志上发表科学论文[鲁白的讲座]

这是著名科学家鲁白先生的讲座,专门针对如何发表国际一流SCI杂志。鲁白发表了大量Nature, Science, Cell等文章,在华人中有较高的影响力。他的讲座通俗易懂,对于发表和设计高级别SCI论文极有好处。 how to publish papers on international Journals.pdf

MedSci参加2009世界高血压大会暨第11届国际高血压及相关疾病研讨会

2009年11月1日,由世界高血压联盟(WHL)与中国高血压联盟(CHL)联合主办的“2009世界高血压大会暨第11届国际高血压及相关疾病研讨会”在北京圆满落下帷幕。 MedSCI工作人员有幸参加了此次大会。 本次大会是世界高血压联盟召开的首次全球性盛会,吸引了来自全球的86家联盟成员参与。 250多位知名专家和学者,他们和来自全球及国内高血压、心血管、内分泌及肾病领域的近4000余名临床医

MedSci参加第三届亚太地区男科学论坛

10月10日,“第三届亚太地区男科学论坛(3APFA)暨《亚洲男科学杂志》创刊十周年庆”在南京国际会展中心召开。此次会议由中国科学院上海药物研究所、上海交通大学、南京医科大学主办,《亚洲男科学杂志》编辑部、南京医科大学生殖医学实验室承办,国际男科学会、中国科学院、中华医学会生殖医学分会等协办。此次论坛的主题是“环境、生活方式、遗传/表观遗传与男性健康”。 MedSci应邀参加了此次大会,MedSc

MedSci参加亚洲小核酸会议

2009年10月14日,第一届亚洲小核酸会议(RNAi Asia)暨第二届中国小核酸技术与应用学术会议于昆山隆重开幕,期间来自海内外的近500位专家学者参与了这次学术盛会。

视频: 如何写出完美的SCI论文(2)

视频只有用IE才可以播放,暂不支持其它浏览器。

MedSci成功在天津主办SCI论文写作讲座

2009年10月22日-24日,由天津微生物学会、天津医科大学、天津中医药大学、天津科技大学联合主办的“生物医药科技论文高阶写作研讨班”成功举办,MedSci李欣梅博士、教授作为主要演讲嘉宾之一,详细而深入地介绍中国人在SCI论文写作过程中一些常见的问题,以及解决方案。 目前,我国生物、医药卫生领域蓬勃发展,新成果、新技术不断涌现。科技论文作为成

Baidu
map
Baidu
map
Baidu
map